New HIV biologic shows promise in early trial – but cure still distant
NCT ID NCT07182838
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 32 times
Summary
This early-phase study tests a new biologic treatment in 20 HIV-positive adults without AIDS symptoms. The goal is to see if the therapy can lower the amount of virus in the blood and help the immune system better target HIV. While promising, this is a proof-of-concept trial and not a cure; participants may still need ongoing HIV management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medicine Invention Design Incorporation - IORG0007849 - NPI 1023387701
Rockville, Maryland, 20853, United States
Conditions
Explore the condition pages connected to this study.